Chirality of reduced haloperidol in humans

European Neuropsychopharmacology

Volumn 8, Issue 2, 1998, Pages 127-129

  Eyles, Darryl W ^a   McGrath, John J ^a   Stedman, Terry J ^a   Pond, Susan M ^b  

^a WOLSTON PARK HOSPITAL   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Haloperidol; Reduced haloperidol; Stereoselective metabolism

Indexed keywords

FLUPHENAZINE; HALOPERIDOL; KETONE REDUCTASE; OXIDOREDUCTASE; REDUCED HALOPERIDOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHIRALITY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG METABOLISM; DRUG URINE LEVEL; ENANTIOMER; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; STEREOISOMERISM;

EID: 0031944289     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00049-7     Document Type: Article

References (9)

1. Chang W.H. Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment? Psychopharmacology. 106:1992;289-296.
2. Eyles D.W., Pond S.M. Stereospecific reduction of haloperidol in human tissues. Biochem. Pharmacol. 44:1992;867-871.
3. Eyles D.W., Stedman T.J., Pond S.M. Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms. Psychopharmacology. 116:1994;161-166.
4. Forsman A., Larsson M. Metabolism of haloperidol. Curr. Ther. Res. 4:1978;567-568.
5. Jaen J.C., Caprathe B.W., Priebe S., Wise L.D. Synthesis of the enantiomers of reduced haloperidol. Pharm. Res. 8:1991;1002-1005.
6. Jaen J.C., Caprathe B.W., Pugsley P.A., Wise L.D., Akunne H. Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and receptors. J. Med. Chem. 36:1993;3929-3936.
7. Prelusky D.B., Coutts R.T., Pasutto F.M. Stereospecific metabolic reductions of ketones. J. Pharm. Sci. 71:1982;1390-1393.
8. Someya T., Shibasaki M., Noguchi T., Takahashi S., Inaba T. Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction. J. Clin. Psychopharmacol. 12:1992;169-174.
9. Wu H.L., Otsuka K., Terabe S. Chiral separation of reduced haloperidol by the capillary zone electrophoresis with heptakis (2,6-di-0-methyl)-β-cyclodextrin. J. Liq. Chrom. Rel. Technol. 19:1996;1567-1577.